TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
HWKN

Hawkins Inc

Basic Materials · Specialty Chemicals

126.60$ +2.1% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Income Statement

Hawkins Inc (HWKN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2026), "Revenue" came in at 1,084 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement HWKN
Line item 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
81 88 95 97 98 108 104 107 115 143 160 187 284 257 298 344 350 348 364 414 484 504 556 540 597 775 935 919 974 1,084
61 65 70 73 73 84 76 79 86 110 123 148 222 193 236 278 293 287 298 334 386 417 460 439 473 628 770 726 762 860
20 23 24 24 25 24 28 28 30 33 37 39 62 64 62 66 57 62 66 80 98 87 96 101 124 147 165 194 213 224
– – – – – – – – – – – – – – – 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – – – – – – – –
8.9 9.5 – 11 12 6.9 15 17 18 22 24 27 25 26 30 31 32 34 35 49 59 59 59 59 68 75 77 90 106 124
10 11 12 11 12 14 15 20 18 20 26 27 25 26 30 31 32 34 35 49 59 59 59 59 68 75 77 90 92 109
9.2 12 12 13 13 10 13 8.2 12 13 11 12 37 39 32 35 25 28 30 31 39 -12 37 42 56 71 88 104 121 115
0.0 0.0 – 0.0 0.0 6.2 0.4 2.2 2.2 2.8 3.4 2.7 1.0 7.0 7.8 0.1 0.1 0.0 0.0 0.8 2.6 3.4 3.4 2.5 1.5 1.4 5.2 4.3 5.4 14
11 13 13 16 14 11 13 9.0 13 14 13 13 38 39 32 35 25 28 30 30 36 -15 34 39 56 70 83 101 114 109
4.0 4.9 5.2 6.3 5.5 3.6 5.0 3.3 4.5 4.8 4.9 4.9 14 15 12 14 8.3 10.0 11 12 13 -5.9 9.1 11 15 18 23 26 30 28
6.5 7.8 8.2 9.7 8.6 7.1 8.4 5.8 8.1 8.9 8.1 9.1 24 24 20 23 17 18 19 18 23 -9.2 24 28 41 52 60 75 84 82
11 14 14 15 15 10 16 8.2 15 16 14 17 43 45 39 44 36 41 43 47 60 11 59 63 80 96 117 137 160 175

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?